Membranous glomerulopathy associated with rheumatoid arthritis may respond to rituximab
- 1 January 2008
- journal article
- letter
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 37 (4) , 313-314
- https://doi.org/10.1080/03009740801910338
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeksArthritis & Rheumatism, 2006
- Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2004
- Rituximab for idiopathic membranous nephropathyThe Lancet, 2002
- MEMBRANOUS NEPHROPATHY IN PATIENTS WITH RHEUMATOID ARTHRITISMedicine, 1978